Table 1.

Clinical and Laboratory Features of LGL Leukemia Patients

Patient No. Age/Sex Splenomegaly*RA WBCANC ALC HCTPLT
1  29/F  Yes  No 30,800  310  30,000  26  365,000  
2  68/M  No No  3,800  1,600  1,630  34  158,000  
3  79/M No  No  2,700  100  2,450  31  145,000  
66/M  Yes  No  15,400  8,800  5,100  31 368,000  
5  58/M  Yes  Yes  17,400  3,800 13,050  42  221,000  
6  75/M  No  No  15,700 1,700  13,700  27  386,000  
7  67/M  No  No 12,200  2,400  9,300  42  206,000  
8  68/M  No No  4,500  720  3,375  24  95,000  
9  60/M No  Yes  3,200  1,700  1,000  36  173,000  
10 56/M  Yes  No  15,800  1,100  11,500  30 96,000  
11  63/F  No  No  6,800  270  6,100 37  189,000 
Patient No. Age/Sex Splenomegaly*RA WBCANC ALC HCTPLT
1  29/F  Yes  No 30,800  310  30,000  26  365,000  
2  68/M  No No  3,800  1,600  1,630  34  158,000  
3  79/M No  No  2,700  100  2,450  31  145,000  
66/M  Yes  No  15,400  8,800  5,100  31 368,000  
5  58/M  Yes  Yes  17,400  3,800 13,050  42  221,000  
6  75/M  No  No  15,700 1,700  13,700  27  386,000  
7  67/M  No  No 12,200  2,400  9,300  42  206,000  
8  68/M  No No  4,500  720  3,375  24  95,000  
9  60/M No  Yes  3,200  1,700  1,000  36  173,000  
10 56/M  Yes  No  15,800  1,100  11,500  30 96,000  
11  63/F  No  No  6,800  270  6,100 37  189,000 

All cell counts are per microliter and represent blood values at the time of laboratory studies.

Abbreviations: RA, rheumatoid arthritis; WBC, white blood cell counts; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; HCT, hematocrit (%); PLT, platelet count.

*

Patients no. 1 and 10 had prior splenectomies for symptomatic splenomegaly; patient no. 4 had splenectomy for ITP.

Patients no. 4, 6, and 8 were transfusion-dependent.

or Create an Account

Close Modal
Close Modal